• Science & Technology
• Health & Medicine

Genetic changes in tumours may predict who will respond to immunotherapy

Genetic changes in tumours could be used to predict who will benefit from immunotherapy, and who should receive other treatments.  Genetic changes in tumours could be used to predict who will benefit from immunotherapy, and who should receive other treatments. 

27 January 2021

• Health & Medicine
• Science & Technology

Discovering the BRCA2 gene – 25 years on

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off. 25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

14 January 2021

• Science & Technology

Scientists develop approach for exploiting cancer’s dietary demands

Scientists discover a way to target cancer’s nutritional needs, which could lead to a new way to treat the disease. Scientists discover a way to target cancer’s nutritional needs, which could lead to a new way to treat the disease.

13 January 2021

• Health & Medicine

Ultraviolet radiation causes rare type of eye cancer

Ultraviolet radiation can cause a rare type of eye cancer, conjunctival melanoma. Ultraviolet radiation can cause a rare type of eye cancer, conjunctival melanoma.

11 January 2021

• Health & Medicine

Striking differences seen in COVID-19 responses in cancer patients

A new study funded by Cancer Research UK shows that the immune response to COVID-19 is the same in people with solid tumours compared to those without cancer. A new study funded by Cancer Research UK shows that the immune response to COVID-19 is the same in people with solid tumours compared to those without cancer.

5 January 2021

• Science & Technology
• Policy & Insight

We have a Deal: What does the new UK-EU relationship mean for cancer?

Here’s what we know about how the new UK-EU relationship may affect cancer services and research. Here’s what we know about how the new UK-EU relationship may affect cancer services and research.

4 January 2021

• Science & Technology

Scientists develop new drug that targets pathway found in several hard-to-treat cancers

After decades of no luck, scientists have finally found a way to target the KRAS mutation - a common mutation found in several hard-to-treat cancers. After decades of no luck, scientists have finally found a way to target the KRAS mutation - a common mutation found in several hard-to-treat cancers.

30 December 2020

• Science & Technology
• Policy & Insight

What could DeepMind ‘solving’ the protein folding problem mean for cancer research?

We asked two of our protein specialists, who are trying to understand how the way proteins fold affect cancer outcomes, to give their verdict on the news. We asked two of our protein specialists, who are trying to understand how the way proteins fold affect cancer outcomes, to give their verdict on the news.

23 December 2020

• Health & Medicine

New treatment could spare early-stage rectal cancer patients life-altering side effects

A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer. A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer.

10 December 2020

• Charity News

Cancer Research UK forced to cut research funding due to COVID-19

Due to the effects of COVID-19, Cancer Research UK has had to cut its research funding by £45 million. Due to the effects of COVID-19, Cancer Research UK has had to cut its research funding by £45 million.

8 December 2020

• Science & Technology

The long road to targeting the holy grail of the immune response

A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works. A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works.

9 November 2020

• Health & Medicine
• Policy & Insight

Learning the lessons of COVID-19: Protecting cancer services and research through the pandemic

We're calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve. We're calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve.

9 November 2020